Vomiting rates were significantly lower compared to GLP-1 based treatments like Semaglutide and Liraglutide
Treatment typically begins at 0.25 mg per week, increasing incrementally to a maximum of 2.4 mg, depending on how well the patient tolerates it
Michl, Martin (Department of Ophthalmology, Medical University of Vienna), Mitsch, Christoph (Department of Ophthalmology, Medical University of Vienna)
At their core, UTIs are infections in any part of the urinary system, though most occur in the bladder and urethra
A physician may consider tirzepatide for patients who need medical support for obesity, overweight with weight-related health concerns, insulin resistance, blood sugar concerns, appetite control, or metabolic risk
What it actually does May improve gut permeability at a high dose (~30g/day)